Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
12/2003
12/18/2003WO2003090670A3 Moisturizing skin gel and method
12/18/2003WO2003087087A3 Heterocyclic compounds and their use as modulators of p38 map kinase
12/18/2003WO2003086430A3 Medicinal herbal extract carpediol for treating depression
12/18/2003WO2003086267A3 Multi-phase, multi-compartment capsular system
12/18/2003WO2003082857A3 Lansoprazole polymorphs and processes for preparation thereof
12/18/2003WO2003082817A3 Beta-amino heterocyclic dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes
12/18/2003WO2003082302A3 Bioadhesive directed somatic cell therapy
12/18/2003WO2003082215A3 Synergistic l-methadone compositions and methods of use thereof
12/18/2003WO2003082192A3 Certain pharmaceutically useful substituted aminoalkyl heterocycles
12/18/2003WO2003074504A3 Process and intermediates for preparing phenylthiomethyl-thiazoles or oxazoles
12/18/2003WO2003074500A3 N-aminoacetyl-pyrrolidine-2-carbonitriles and their use as ddp-iv inhibitors
12/18/2003WO2003074474A3 Multiple-component solid phases containing at least one active pharmaceutical ingredient
12/18/2003WO2003074473A3 Irreversible selective androgen receptor modulators and methods of use thereof
12/18/2003WO2003074467A3 Urea derivatives as hiv aspartyl protease inhibitors
12/18/2003WO2003074449A3 Multi-substitued selective androgen receptor modulators and methods of use thereof
12/18/2003WO2003074027A3 Self emulsifying drug delivery systems for poorly soluble drugs
12/18/2003WO2003072019A3 Sequential therapy comprising a 20(s)-camptothecin compound and a pyrimidine base analog
12/18/2003WO2003070701B1 Syntheses of quinazolinones
12/18/2003WO2003068246A3 Improvements in or relating to compositions
12/18/2003WO2003068207A3 Partial dopamine-d2 receptor agonist plus serotonin and/oder noradrenaline inhibitor activity
12/18/2003WO2003066638A3 The synthesis of naturally occuring ecteinascidins and related compounds
12/18/2003WO2003066630A3 Quinolinone derivatives for treating cell proliferation related disorders
12/18/2003WO2003066593A3 Preparation of pharmaceutical salts of 4 ( (z) - (4-bromophenyl) (ethoxyimino) methyl )-1'-( (2,4-dimethyl-1-oxido-3-pyridinyl) carbonyl) -4'-methyl-1,4' bipiperidine as ccr5-antagonists for the treatment of aids and related hiv infections
12/18/2003WO2003064431A3 Aminopiperidine compounds, process for their preparation, and pharmaceutical compositions containing them
12/18/2003WO2003063927A3 Compositions and methods to treat gastrointestinal disorders
12/18/2003WO2003061704A3 Combination therapy for the treatment of bacterial infections
12/18/2003WO2003059297A3 Dermatological topical compositions and a process for the preparation thereof
12/18/2003WO2003057911A3 Single nucleotide polymorphisms predicting cardiovascular disease and medication efficacy
12/18/2003WO2003057159A3 Psoriasin expression by breast epithelial cells
12/18/2003WO2003057135A3 Aqueous compositions containing metronidazole
12/18/2003WO2003055977A3 A method for generating overexpression of alleles in genes of unknown function
12/18/2003WO2003053431A3 Pharmaceutical compositions based on azetidine derivatives
12/18/2003WO2003053417A3 Method for making a tablet comprising a morphine type analgesic and resulting tablet
12/18/2003WO2003051917A3 Novel death associated proteins of the thap family and related par4 pathways involved in apoptosis control
12/18/2003WO2003051307A3 Materials and methods for the treatment or prevention of obesity
12/18/2003WO2003051306A3 N4-acylcytosine-1,3-dioxolane nucleosides for treatment of viral infections
12/18/2003WO2003051301A3 USE OF dsRNAs IN STRATEGIC THERAPEUTIC INTERVENTION OF HIGHLY ACTIVE ANTIRETROVIRAL THERAPY
12/18/2003WO2003051297A3 Aqueous ifosfamide composition
12/18/2003WO2003051281A3 Composition and method to treat viral bacterial and parasitic infections and infestations
12/18/2003WO2003050108A8 Salt forms of e-2-methoxy-n-(3-(4-(3-methyl-pyridin-3-yloxy)-phenylamino)-quinazolin-6-yl)-allyl)-acetamide, its preparation and its use against cancer
12/18/2003WO2003050064B1 Mitotic kinesin inhibitors
12/18/2003WO2003049599A3 Methods and compositions for the diagnosis of asthma
12/18/2003WO2003048298A3 Nanoparticles containing polymeric nucleic acid homologs, pharmaceutical compositions and articles of manufacture containing same and methods of use thereof
12/18/2003WO2003047528A3 Supplements containing annatto extracts and carotenoids and methods for using the same
12/18/2003WO2003047503A3 Delivery of medicaments to the nail
12/18/2003WO2003046179A3 G-protein coupled receptor lustr2 and uses thereof
12/18/2003WO2003045363A3 Treatment of th2 dominated immunological disease states with progesterone receptor antagonists
12/18/2003WO2003045362A3 Treatment of th1 dominated immunological disease states with non-endogenous gestagen compounds
12/18/2003WO2003045359A3 Combination of cimetidine and cysteine derivatives for treating cancer
12/18/2003WO2003044021A3 Substituted indolizine-like compounds and methods of use
12/18/2003WO2003040309A3 Peptides acting as both glp-1 receptor agonists and glucagon receptor antagonists and their pharmacological methods of use
12/18/2003WO2003039677A3 Covalent conjugates of biologically-active compounds with amino acids and amino acid derivatives for targeting to physiologically-protected sites
12/18/2003WO2003039477A9 Generation of virus-like particles and demonstration of lipid rafts as sites of filovirus entry and budding
12/18/2003WO2003039440A3 Substituted 4-phenyl-4-(1h-imidazol-2-yl)-piperidine derivatives for reducing ischaemic damage
12/18/2003WO2003037164A3 Methods and compositions for the diagnosis and treatment of hematological disorders using 2777
12/18/2003WO2003032926A3 Compositions and methods for reversal of drug resistance
12/18/2003WO2003031606A3 Crystal structure of an aurora kinase catalytic domain, and use thereof
12/18/2003WO2003028712A3 Purinergic and pyrimidinergic receptor agonists for the treatment of activated cd4+ t lymphocyte-mediated immune diseases
12/18/2003WO2003027244A3 Antisense oligonucleotides and methods to induce tumor cell death
12/18/2003WO2003027234A3 Small organic molecule regulators of cell proliferation
12/18/2003WO2003024407A3 Inhibitors of rnase p proteins as antibacterial compounds
12/18/2003WO2003022804A9 Method for the preparation of crystalline tetrahydrobenzothiepines
12/18/2003WO2003015773A3 2-amino-4,5-trisubstituted thiazolyl derivatives and their use against autoimmune diseases
12/18/2003WO2003015700A3 Novel vasoconstrictor cannabinoid analogs
12/18/2003WO2003013536A3 Methods for treatment of cancer using irinotecan based on ugt1a1
12/18/2003WO2003011263A3 Use of a lactate salt for the treatment and prophylaxis of atherosclerosis
12/18/2003WO2003006045A3 Cxcl10 treatment of secondary tissue degeneration
12/18/2003WO2003000228A3 Method for high through put screening using a small scale mill or microfluidics
12/18/2003WO2003000220B1 Use of 1,2-decandiol for combating germs causing body odour
12/18/2003WO2002097045A3 Neuroblastoma cell lines expressing the alpha2delta subunit of calcium channels and methods therefore
12/18/2003WO2002092788A3 Cytotoxic peptides and peptidomimetics based thereon, and methods for use thereof
12/18/2003WO2002090543A3 Regulation of human phosphatidic acid phosphatase type 2c-like protein
12/18/2003WO2002090375A3 Liver x receptor agonists
12/18/2003WO2002081668A3 Desaturase genes and uses thereof
12/18/2003WO2002067941A8 Combination comprising a signal transduction inhibitor and an epothilone derivative
12/18/2003WO2002067916A3 Pharmaceutical salts
12/18/2003WO2002062398A3 Radioactively labelled conjugates of phosphonates
12/18/2003WO2002060871A8 Benzenesulfonic acid indol-5-yl esters as antagonists of the 5-ht6 receptor
12/18/2003WO2002057492A9 Methods and compositions for detecting polynucleotide duplex damage
12/18/2003WO2002041883A3 As-needed administration of tricyclic and other non-sri antidepressant drugs to treat premature ejaculation
12/18/2003WO2002038561A8 Indolylmaleimide derivatives as protein kinase c inhibitors
12/18/2003WO2002032435A9 A composition including a platelet activating factor inhibitor and an antioxidant which interferes with the arachidonic acid cascade
12/18/2003WO2002030257A9 Normalization of defective t cell responsiveness through manipulation of thymic regeneration
12/18/2003WO2002014536A9 Odulating multiple lineage kinase proteins
12/18/2003WO2001091734A8 Composition for the treatment and/or the prevention of osteoporosis and/or inflammatory joint diseases
12/18/2003US20030233086 Drug delivery system for conscious sedation
12/18/2003US20030233084 Compositions, methods and devices for treatment of urethral disorders
12/18/2003US20030233015 Sulfonamide derivatives
12/18/2003US20030232993 Process for preparing scopine esters
12/18/2003US20030232992 Reacting, in the presence of a metal catalyst, a halogenobenzoic acid derivative with benzene derivative to produce biphenyldicarboxylic acid amide derivative
12/18/2003US20030232990 For therapy of arteriosclerosis and dyslipidaemias
12/18/2003US20030232986 Inhibitors of caspases
12/18/2003US20030232985 For therapy of Alzheimer's disease and Down's Syndrome
12/18/2003US20030232981 Contacting a Delta 3,5-3-enol ether of formula (alkyl enol ether) with a hydride abstractor and an alcohol
12/18/2003US20030232944 Applying to the tissue formulation comprising first precursor component second precursor component comprises electrophilic component which crosslink at physiological temperatures over a period of time following application
12/18/2003US20030232893 Method of treating rosacea
12/18/2003US20030232892 Microcrystalline zeaxanthin with high bioavailability in oily carrier formulations
12/18/2003US20030232891 For therapy of pain
12/18/2003US20030232890 Methods for treating an impairment in memory consolidation
12/18/2003US20030232889 For therapy of cancer, restenosis, psoriasis, autoimmune disease, atherosclerosis, osteoarthritis, rheumatoid arthritis, heart failure, chronic pain, and neuropathic pain
1 ... 5238 5239 5240 5241 5242 5243 5244 5245 5246 5247 5248 5249 5250 5251 5252 5253 5254 5255 5256 5257 5258 ... 7860